Ligand Pharmaceuticals Inc

Ownership Transactions Reported by 17 Insiders

Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Location
3911 Sorrento Valley Blvd, Suite 110, San Diego, CA

Insiders trading volume in the past year

Ligand Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John L. Higgins Director $30.2M Dec 28, 2022
Jason Aryeh Director $20.5M -$1.71M -7.7% Sep 23, 2025
Todd C. Davis Chief Executive Officer, Director $14.7M +$1M +7.3% Jun 30, 2025
Matthew W. Foehr Former Executive Officer $11.7M Nov 1, 2022
John W. Kozarich Director $8.16M -$338K -3.97% Oct 1, 2025
Matthew Korenberg President & COO $5.18M Sep 20, 2024
Andrew Reardon CLO & Secretary $4.62M -$218K -4.51% Aug 10, 2025
Stephen L. Sabba Director $3.69M Jun 6, 2025
John L. Lamattina Director $3.35M -$298K -8.15% Jun 6, 2025
Octavio Espinoza Chief Financial Officer $2.72M -$664K -19.6% Jun 30, 2025
Sunil Patel Former Director $2.08M Nov 1, 2022
Charles S. Berkman Former Executive Officer $1.72M Nov 1, 2022
Nancy Ryan Gray Director $883K Jun 6, 2025
Martine Zimmermann Director $759K Sep 22, 2025
Jason Haas Director $721K Jun 6, 2025
Sarah Boyce Former Director $209K Nov 1, 2022
Jennifer R. Cochran Former Director $84K Nov 1, 2022

Recent Insider Transactions by Companies or Individuals for Ligand Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.